Note: Ingredients listed on restricted chemical lists
EC/CAS
2855-13-2
Name of the chemical
3-aminomethyl-3,5,5-trimethylcyclohexylamine
Concentration
0.1-40
EC/CAS
19900-65-3
Name of the chemical
4,4'-methylenebis(2-ethylaniline)
Concentration
0.1-40
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
10-25
General Information
Revision date
2015-06-01
Product name
METCOSEAL ERS, Part B
supplier name
Oerlikon Metco (US) Inc
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
Oerlikon Metco (US) Inc
GHS Information
Signal word
CAUTION!
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Emergency overview Physical state Liquid. [Viscous liquid.] Color : Tan. Odor : Amine-like.
Signal word
CAUTION!
Hazard statements
MAY BE HARMFUL IF ABSORBED THROUGH SKIN OR IF SWALLOWED. MAY CAUSE EYE AND SKIN IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Precautionary statements
Do not breathe vapor or mist. Do not ingest. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Avoid prolonged contact with eyes, skin and clothing. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Harmful if swallowed. Skin Harmful in contact with skin. Eyes Causes eye irritation.
Potential chronic health
effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: skin, eye, lens or cornea. Over-exposure signs/symptoms Inhalation : No specific data. Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this SDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)